ReviewClinical Medicine Insights. Oncology2018
Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach.
Niamh Coleman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it